Recent Updates
Recently added Catalysts
BBIO Positive Sentiment Score: 70/100

BridgeBio Pharma to Participate in September Investor Events

Wednesday, August 28, 2024 1 min read
Key Takeaway: BridgeBio Pharma, a biopharmaceutical firm focused on genetic diseases, has announced its upcoming participation in several investor conferences. Notable events include the Morgan Stanley 22nd Annual Global Health Care Conference and the Wells Fargo 19th Annual Healthcare Conference, slated for September 4th and 5th, respectively. The company will also present at the Cantor Global Healthcare Conference on September 17th. Webcasts of these presentations will be accessible through their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • BridgeBio is actively engaging with investors, indicating strong market interest.
  • The company's participation in multiple prestigious healthcare conferences enhances its visibility.
  • Upcoming webcasts provide transparency and accessibility for potential investors.

Full Press Release Details

PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences:
Morgan Stanley 22nd Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4th at 10:00 am ET
Wells Fargo 19th Annual Healthcare Conference 2024, Boston, MA, September 5th
Cantor Global Healthcare Conference, New York, NY: Presentation on September 17th at 10:20 am ET
To access the live webcast of BridgeBio’s presentations, please visit the “Events” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
contact@bridgebio.com

Frequently Asked Questions

Which conferences will BridgeBio Pharma attend in September 2024?

BridgeBio Pharma will attend the Morgan Stanley and Wells Fargo conferences on September 4th and 5th, respectively.

When is BridgeBio's presentation at the Cantor Global Healthcare Conference?

BridgeBio will present at the Cantor Global Healthcare Conference on September 17th at 10:20 am ET.

How can I access BridgeBio's conference presentations?

Live webcasts of BridgeBio's presentations can be accessed on their Investors page at their website.

Will the conference webcasts be available after the events?

Yes, a replay of the webcasts will be available for 90 days after each event.

Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio investor conferences genetic diseases healthcare
Last updated: Aug 28, 2024